APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sevoflurane (Sevoflurane Source)

Sevoflurane is a halogenated general inhalation anesthetic drug.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Sevoflurane is a halogenated general inhalation anesthetic drug.

Selected research

Market Structure

Global Sevoflurane (Sevoflurane Source) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026182 pages

Choose your research edition.

Industry ResearchSevoflurane (Sevoflurane Source) Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Sevoflurane (Sevoflurane Source) Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Sevoflurane (Sevoflurane Source) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sevoflurane (Sevoflurane Source) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Sevoflurane (Sevoflurane Source) Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Sevoflurane is a halogenated general inhalation anesthetic drug.

The top 5 players was expected to reach at about 65% market share by 2020, in terms of the globle sevoflurane revenue.

Report Includes

Read the full market overview

This report provides an overview of the global Sevoflurane (Sevoflurane Source) market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sevoflurane (Sevoflurane Source) and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sevoflurane (Sevoflurane Source) revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Sevoflurane (Sevoflurane Source) market size, projected growth trends, production technologies, key applications, and end-use industries.

Sevoflurane (Sevoflurane Source) Segment by Company

Abbott(AbbVie)

Baxter

Maruishi Pharmaceutical

Jiangsu Hengrui

Lunan

Sevoflurane (Sevoflurane Source) Segment by Type

Original Drugs

Generic Drugs

Sevoflurane (Sevoflurane Source) Segment by Application

For Human

For Animal

Sevoflurane (Sevoflurane Source) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sevoflurane (Sevoflurane Source) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sevoflurane (Sevoflurane Source) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sevoflurane (Sevoflurane Source).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Sevoflurane (Sevoflurane Source) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sevoflurane (Sevoflurane Source) industry.

Chapter 3: Detailed analysis of Sevoflurane (Sevoflurane Source) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sevoflurane (Sevoflurane Source)revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sevoflurane (Sevoflurane Source) Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Original Drugs Table 3. Key Players of Generic Drugs Table 4. Global Sevoflurane (Sevoflurane Source) Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of For Human Table 6. Key Players of For Animal Table 7. Global Sevoflurane (Sevoflurane Source) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Sevoflurane (Sevoflurane Source) Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Sevoflurane (Sevoflurane Source) Market Share by Region (2021-2026) Table 10. Global Sevoflurane (Sevoflurane Source) Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Sevoflurane (Sevoflurane Source) Market Share by Region (2027-2032) Table 12. Sevoflurane (Sevoflurane Source) Industry Trends Table 13. Sevoflurane (Sevoflurane Source) Industry Drivers Table 14. Sevoflurane (Sevoflurane Source) Industry Opportunities and Challenges Table 15. Sevoflurane (Sevoflurane Source) Industry Restraints Table 16. Global Sevoflurane (Sevoflurane Source) Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Company (2021-2026) Table 18. Global Sevoflurane (Sevoflurane Source) Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Sevoflurane (Sevoflurane Source) Key Company Head Office and Area Served Table 20. Global Sevoflurane (Sevoflurane Source) Company, Product Type & Application Table 21. Global Sevoflurane (Sevoflurane Source) Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Sevoflurane (Sevoflurane Source) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Sevoflurane (Sevoflurane Source) Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Sevoflurane (Sevoflurane Source) Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Sevoflurane (Sevoflurane Source) Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Type (2021-2026) Table 28. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Type (2027-2032) Table 29. Global Sevoflurane (Sevoflurane Source) Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Sevoflurane (Sevoflurane Source) Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Sevoflurane (Sevoflurane Source) Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Application (2021-2026) Table 33. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Application (2027-2032) Table 34. Abbott(AbbVie) Company Information Table 35. Abbott(AbbVie) Business Overview Table 36. Abbott(AbbVie) Sevoflurane (Sevoflurane Source) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Abbott(AbbVie) Sevoflurane (Sevoflurane Source) Product Portfolio Table 38. Abbott(AbbVie) Recent Development Table 39. Baxter Company Information Table 40. Baxter Business Overview Table 41. Baxter Sevoflurane (Sevoflurane Source) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Baxter Sevoflurane (Sevoflurane Source) Product Portfolio Table 43. Baxter Recent Development Table 44. Maruishi Pharmaceutical Company Information Table 45. Maruishi Pharmaceutical Business Overview Table 46. Maruishi Pharmaceutical Sevoflurane (Sevoflurane Source) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Maruishi Pharmaceutical Sevoflurane (Sevoflurane Source) Product Portfolio Table 48. Maruishi Pharmaceutical Recent Development Table 49. Jiangsu Hengrui Company Information Table 50. Jiangsu Hengrui Business Overview Table 51. Jiangsu Hengrui Sevoflurane (Sevoflurane Source) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Jiangsu Hengrui Sevoflurane (Sevoflurane Source) Product Portfolio Table 53. Jiangsu Hengrui Recent Development Table 54. Lunan Company Information Table 55. Lunan Business Overview Table 56. Lunan Sevoflurane (Sevoflurane Source) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Lunan Sevoflurane (Sevoflurane Source) Product Portfolio Table 58. Lunan Recent Development Table 59. North America Sevoflurane (Sevoflurane Source) Market Size by Type (2021-2026) & (US$ Million) Table 60. North America Sevoflurane (Sevoflurane Source) Market Size by Type (2027-2032) & (US$ Million) Table 61. North America Sevoflurane (Sevoflurane Source) Market Size by Application (2021-2026) & (US$ Million) Table 62. North America Sevoflurane (Sevoflurane Source) Market Size by Application (2027-2032) & (US$ Million) Table 63. North America Sevoflurane (Sevoflurane Source) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 64. North America Sevoflurane (Sevoflurane Source) Market Size by Country (2021-2026) Table 65. North America Sevoflurane (Sevoflurane Source) Market Size by Country (2027-2032) Table 66. Europe Sevoflurane (Sevoflurane Source) Market Size by Type (2021-2026) & (US$ Million) Table 67. Europe Sevoflurane (Sevoflurane Source) Market Size by Type (2027-2032) & (US$ Million) Table 68. Europe Sevoflurane (Sevoflurane Source) Market Size by Application (2021-2026) & (US$ Million) Table 69. Europe Sevoflurane (Sevoflurane Source) Market Size by Application (2027-2032) & (US$ Million) Table 70. Europe Sevoflurane (Sevoflurane Source) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 71. Europe Sevoflurane (Sevoflurane Source) Market Size by Country (2021-2026) Table 72. Europe Sevoflurane (Sevoflurane Source) Market Size by Country (2027-2032) Table 73. China Sevoflurane (Sevoflurane Source) Market Size by Type (2021-2026) & (US$ Million) Table 74. China Sevoflurane (Sevoflurane Source) Market Size by Type (2027-2032) & (US$ Million) Table 75. China Sevoflurane (Sevoflurane Source) Market Size by Application (2021-2026) & (US$ Million) Table 76. China Sevoflurane (Sevoflurane Source) Market Size by Application (2027-2032) & (US$ Million) Table 77. Asia Sevoflurane (Sevoflurane Source) Market Size by Type (2021-2026) & (US$ Million) Table 78. Asia Sevoflurane (Sevoflurane Source) Market Size by Type (2027-2032) & (US$ Million) Table 79. Asia Sevoflurane (Sevoflurane Source) Market Size by Application (2021-2026) & (US$ Million) Table 80. Asia Sevoflurane (Sevoflurane Source) Market Size by Application (2027-2032) & (US$ Million) Table 81. Asia Sevoflurane (Sevoflurane Source) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Asia Sevoflurane (Sevoflurane Source) Market Size by Country (2021-2026) Table 83. Asia Sevoflurane (Sevoflurane Source) Market Size by Country (2027-2032) Table 84. South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Type (2021-2026) & (US$ Million) Table 85. South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Type (2027-2032) & (US$ Million) Table 86. South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Application (2021-2026) & (US$ Million) Table 87. South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Application (2027-2032) & (US$ Million) Table 88. South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Country (2021-2026) Table 90. South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Country (2027-2032) Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Sevoflurane (Sevoflurane Source) Product Image Figure 2. Global Sevoflurane (Sevoflurane Source) Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Sevoflurane (Sevoflurane Source) Market Share by Type: 2025 VS 2032 Figure 4. Original Drugs Image Figure 5. Generic Drugs Image Figure 6. Global Sevoflurane (Sevoflurane Source) Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Sevoflurane (Sevoflurane Source) Market Share by Application: 2025 VS 2032 Figure 8. For Human Image Figure 9. For Animal Image Figure 10. Global Sevoflurane (Sevoflurane Source) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 12. Global Sevoflurane (Sevoflurane Source) Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global Sevoflurane (Sevoflurane Source) Market Share by Players in 2025 Figure 15. Global Top 5 and 10 Sevoflurane (Sevoflurane Source) Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Sevoflurane (Sevoflurane Source) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Type (2021-2032) Figure 19. Global Sevoflurane (Sevoflurane Source) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Sevoflurane (Sevoflurane Source) Revenue Market Share by Application (2021-2032) Figure 21. North America Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 22. North America Sevoflurane (Sevoflurane Source) Market Share by Type (2021-2032) Figure 23. North America Sevoflurane (Sevoflurane Source) Market Share by Application (2021-2032) Figure 24. North America Sevoflurane (Sevoflurane Source) Market Share by Country (2021-2032) Figure 25. United States Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 26. Canada Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 27. Mexico Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 28. Europe Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 29. Europe Sevoflurane (Sevoflurane Source) Market Share by Type (2021-2032) Figure 30. Europe Sevoflurane (Sevoflurane Source) Market Share by Application (2021-2032) Figure 31. Europe Sevoflurane (Sevoflurane Source) Market Share by Country (2021-2032) Figure 32. Germany Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 33. France Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 34. U.K. Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 35. Italy Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 36. Russia Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 38. China Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 39. China Sevoflurane (Sevoflurane Source) Market Share by Type (2021-2032) Figure 40. China Sevoflurane (Sevoflurane Source) Market Share by Application (2021-2032) Figure 41. Asia Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 42. Asia Sevoflurane (Sevoflurane Source) Market Share by Type (2021-2032) Figure 43. Asia Sevoflurane (Sevoflurane Source) Market Share by Application (2021-2032) Figure 44. Asia Sevoflurane (Sevoflurane Source) Market Share by Country (2021-2032) Figure 45. Japan Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 46. South Korea Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 49. India Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 50. Australia Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Share by Country (2021-2032) Figure 55. Brazil Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 56. South Africa Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 58. Turkey Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 59. Argentina Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 60. UAE Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 61. Egypt Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 62. Chile Sevoflurane (Sevoflurane Source) Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drugs
  • Generic Drugs
Applications
  • For Human
  • For Animal
Companies covered
  • Abbott(AbbVie)
  • Baxter
  • Maruishi Pharmaceutical
  • Jiangsu Hengrui
  • Lunan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Sevoflurane (Sevoflurane Source) Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Original Drugs
  5. 1.2.3 Generic Drugs
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Sevoflurane (Sevoflurane Source) Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 For Human
  9. 1.3.3 For Animal
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global Sevoflurane (Sevoflurane Source) Growth Trends by Region
  12. 1.5.1 Global Sevoflurane (Sevoflurane Source) Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 Sevoflurane (Sevoflurane Source) Market Size by Region (2021-2026)
  14. 1.5.3 Sevoflurane (Sevoflurane Source) Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global Sevoflurane (Sevoflurane Source) Market Dynamics
  1. 2.1 Sevoflurane (Sevoflurane Source) Industry Trends
  2. 2.2 Sevoflurane (Sevoflurane Source) Industry Drivers
  3. 2.3 Sevoflurane (Sevoflurane Source) Industry Opportunities and Challenges
  4. 2.4 Sevoflurane (Sevoflurane Source) Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Sevoflurane (Sevoflurane Source) Revenue by Company (2021-2026)
  2. 3.2 Global Sevoflurane (Sevoflurane Source) Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Sevoflurane (Sevoflurane Source) Key Company Head office and Area Served
  4. 3.4 Global Sevoflurane (Sevoflurane Source) Company, Product Type & Application
  5. 3.5 Global Sevoflurane (Sevoflurane Source) Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Sevoflurane (Sevoflurane Source) Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Sevoflurane (Sevoflurane Source) Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Sevoflurane (Sevoflurane Source) Tier 1, Tier 2, and Tier 3
4 Sevoflurane (Sevoflurane Source) Market by Type
  1. 4.1 Global Sevoflurane (Sevoflurane Source) Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Sevoflurane (Sevoflurane Source) Market Size by Type (2021-2032)
  3. 4.3 Global Sevoflurane (Sevoflurane Source) Market Size Share by Type (2021-2032)
5 Sevoflurane (Sevoflurane Source) Market by Application
  1. 5.1 Global Sevoflurane (Sevoflurane Source) Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Sevoflurane (Sevoflurane Source) Market Size by Application (2021-2032)
  3. 5.3 Global Sevoflurane (Sevoflurane Source) Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Abbott(AbbVie)
  2. 6.1.1 Abbott(AbbVie) Company Information
  3. 6.1.2 Abbott(AbbVie) Business Overview
  4. 6.1.3 Abbott(AbbVie) Sevoflurane (Sevoflurane Source) Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Abbott(AbbVie) Sevoflurane (Sevoflurane Source) Product Portfolio
  6. 6.1.5 Abbott(AbbVie) Recent Developments
  7. 6.2 Baxter
  8. 6.2.1 Baxter Company Information
  9. 6.2.2 Baxter Business Overview
  10. 6.2.3 Baxter Sevoflurane (Sevoflurane Source) Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Baxter Sevoflurane (Sevoflurane Source) Product Portfolio
  12. 6.2.5 Baxter Recent Developments
  13. 6.3 Maruishi Pharmaceutical
  14. 6.3.1 Maruishi Pharmaceutical Company Information
  15. 6.3.2 Maruishi Pharmaceutical Business Overview
  16. 6.3.3 Maruishi Pharmaceutical Sevoflurane (Sevoflurane Source) Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Maruishi Pharmaceutical Sevoflurane (Sevoflurane Source) Product Portfolio
  18. 6.3.5 Maruishi Pharmaceutical Recent Developments
  19. 6.4 Jiangsu Hengrui
  20. 6.4.1 Jiangsu Hengrui Company Information
  21. 6.4.2 Jiangsu Hengrui Business Overview
  22. 6.4.3 Jiangsu Hengrui Sevoflurane (Sevoflurane Source) Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Jiangsu Hengrui Sevoflurane (Sevoflurane Source) Product Portfolio
  24. 6.4.5 Jiangsu Hengrui Recent Developments
  25. 6.5 Lunan
  26. 6.5.1 Lunan Company Information
  27. 6.5.2 Lunan Business Overview
  28. 6.5.3 Lunan Sevoflurane (Sevoflurane Source) Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Lunan Sevoflurane (Sevoflurane Source) Product Portfolio
  30. 6.5.5 Lunan Recent Developments
7 North America
  1. 7.1 North America Sevoflurane (Sevoflurane Source) Market Size (2021-2032)
  2. 7.2 North America Sevoflurane (Sevoflurane Source) Market Size by Type
  3. 7.2.1 North America Sevoflurane (Sevoflurane Source) Market Size by Type (2021-2026)
  4. 7.2.2 North America Sevoflurane (Sevoflurane Source) Market Size by Type (2027-2032)
  5. 7.2.3 North America Sevoflurane (Sevoflurane Source) Market Share by Type (2021-2032)
  6. 7.3 North America Sevoflurane (Sevoflurane Source) Market Size by Application
  7. 7.3.1 North America Sevoflurane (Sevoflurane Source) Market Size by Application (2021-2026)
  8. 7.3.2 North America Sevoflurane (Sevoflurane Source) Market Size by Application (2027-2032)
  9. 7.3.3 North America Sevoflurane (Sevoflurane Source) Market Share by Application (2021-2032)
  10. 7.4 North America Sevoflurane (Sevoflurane Source) Market Size by Country
  11. 7.4.1 North America Sevoflurane (Sevoflurane Source) Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Sevoflurane (Sevoflurane Source) Market Size by Country (2021-2026)
  13. 7.4.3 North America Sevoflurane (Sevoflurane Source) Market Size by Country (2027-2032)
  14. 7.4.4 North America Sevoflurane (Sevoflurane Source) Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Sevoflurane (Sevoflurane Source) Market Size (2021-2032)
  2. 8.2 Europe Sevoflurane (Sevoflurane Source) Market Size by Type
  3. 8.2.1 Europe Sevoflurane (Sevoflurane Source) Market Size by Type (2021-2026)
  4. 8.2.2 Europe Sevoflurane (Sevoflurane Source) Market Size by Type (2027-2032)
  5. 8.2.3 Europe Sevoflurane (Sevoflurane Source) Market Share by Type (2021-2032)
  6. 8.3 Europe Sevoflurane (Sevoflurane Source) Market Size by Application
  7. 8.3.1 Europe Sevoflurane (Sevoflurane Source) Market Size by Application (2021-2026)
  8. 8.3.2 Europe Sevoflurane (Sevoflurane Source) Market Size by Application (2027-2032)
  9. 8.3.3 Europe Sevoflurane (Sevoflurane Source) Market Share by Application (2021-2032)
  10. 8.4 Europe Sevoflurane (Sevoflurane Source) Market Size by Country
  11. 8.4.1 Europe Sevoflurane (Sevoflurane Source) Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Sevoflurane (Sevoflurane Source) Market Size by Country (2021-2026)
  13. 8.4.3 Europe Sevoflurane (Sevoflurane Source) Market Size by Country (2027-2032)
  14. 8.4.4 Europe Sevoflurane (Sevoflurane Source) Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Sevoflurane (Sevoflurane Source) Market Size (2021-2032)
  2. 9.2 China Sevoflurane (Sevoflurane Source) Market Size by Type
  3. 9.2.1 China Sevoflurane (Sevoflurane Source) Market Size by Type (2021-2026)
  4. 9.2.2 China Sevoflurane (Sevoflurane Source) Market Size by Type (2027-2032)
  5. 9.2.3 China Sevoflurane (Sevoflurane Source) Market Share by Type (2021-2032)
  6. 9.3 China Sevoflurane (Sevoflurane Source) Market Size by Application
  7. 9.3.1 China Sevoflurane (Sevoflurane Source) Market Size by Application (2021-2026)
  8. 9.3.2 China Sevoflurane (Sevoflurane Source) Market Size by Application (2027-2032)
  9. 9.3.3 China Sevoflurane (Sevoflurane Source) Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Sevoflurane (Sevoflurane Source) Market Size (2021-2032)
  2. 10.2 Asia Sevoflurane (Sevoflurane Source) Market Size by Type
  3. 10.2.1 Asia Sevoflurane (Sevoflurane Source) Market Size by Type (2021-2026)
  4. 10.2.2 Asia Sevoflurane (Sevoflurane Source) Market Size by Type (2027-2032)
  5. 10.2.3 Asia Sevoflurane (Sevoflurane Source) Market Share by Type (2021-2032)
  6. 10.3 Asia Sevoflurane (Sevoflurane Source) Market Size by Application
  7. 10.3.1 Asia Sevoflurane (Sevoflurane Source) Market Size by Application (2021-2026)
  8. 10.3.2 Asia Sevoflurane (Sevoflurane Source) Market Size by Application (2027-2032)
  9. 10.3.3 Asia Sevoflurane (Sevoflurane Source) Market Share by Application (2021-2032)
  10. 10.4 Asia Sevoflurane (Sevoflurane Source) Market Size by Country
  11. 10.4.1 Asia Sevoflurane (Sevoflurane Source) Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Sevoflurane (Sevoflurane Source) Market Size by Country (2021-2026)
  13. 10.4.3 Asia Sevoflurane (Sevoflurane Source) Market Size by Country (2027-2032)
  14. 10.4.4 Asia Sevoflurane (Sevoflurane Source) Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Sevoflurane (Sevoflurane Source) Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst